Y5 - Ovarian tumour (benign and malignant) Flashcards

1
Q

what provides a definitive diagnosis of ovarian cancer

A

surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

def of an epithelial ovarian cancer

A

a malignant transformation of the ovarian capsule epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are different sub-types of ovarian cancer

A

epithelial, germ cell, and sex-cord tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

aetiology

A

genetic causes implicated

  • BRCA1/2
  • HNPCC mutations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

where do ovarian cancers often originate

A

the fallopian tubes at the distal fimbral portion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

does epithelial ovarian cancer invade organ space

A

normally no, usually attaches to the surface of organs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

epi

A

most lethal gynaecological cancer

elderly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

is ovarian cancer more common in white women or black women

A

white women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

RFs

A

increasing age
FHx of ovarian/breast cancer
never used OCP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what does OCP protect against

A

ovarian cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

signs and symptoms

A
RFs
pelvic mass
-adnexal mass
GI symptoms > 3 months
-bloading
-nausea
-dyspepsia
-urinary incontinence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

features of BRCA1 mutation

A

found on chr 17q

autosomal dominant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the increased risk of ovarian cancer with a BRCA1 mutation

A

35% increased lifetime risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

features of BRCA2 mutation

A

found on chr 13q

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the increased risk of ovarian cancer with a BRCA2 mutation

A

30%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

first line investigation

A

pelvic ultrasound

  • solid mass
  • high blood flow (doppler)
17
Q

what cancer antigen marker is raised in ovarian cancer

18
Q

what is the definitive test for ovarian cancer

A

surgery and histopathology

19
Q

why do patients commonly present at late stages of ovarian cancer

A

due to vague and non-specific symptoms

20
Q

what are the four stages of ovarian cancer

A

Stage 1 - confined to ovaries
Stage 2 - involves pelvic extension or primary peritoneal cancer
Stage 3 - spread to the peritoneum outside the pelvis or metastasis to retroperitoneal lymph ndoes
stage 4 - distant metastasis

21
Q

what are the cornerstones of ovarian cancer treatment

A

surgery and chemotherapy

22
Q

what is standard therapy for ovarian cancer

A

maximal surgical debulking and chemotherapy

23
Q

management for stage I ovarian cancer

24
Q

management for stages II-IV ovarian cancer with optimal debulking

A

IV and intraperitoneal chemotherapy with paclitaxel and cisplatin

25
management for stages II-IV ovarian cancer with sub-optimal debulking
IV chemotherapy with carboplatin and paclitaxel OR docetaxel
26
management for platinum sensitive recurrent disease
carboplatin and paclitacel or doxorubicin liposomal
27
management for platinum resistant recurrent disease
doxorubicin liposomal
28
prevention for ovarian cancer
OCP
29
complications
intraperitoneal therapy failure plantar-palmar erythrodysaesthesia alopecia
30
what causes plantar-palmar erythrodysaesthesia
doxorubicin liposomal
31
what is plantar-palmar erythrodysaesthesia
paraesthesia with painful redness of palms and soles
32
prognosis
majority of patients have remission after first line therapy
33
what is the most important prognostic factor for relapse
treatment-free interval or time from completion of first line therapy to reoccurrance
34
what has worse prognosis, platinum sensitive or platinum resistant ovarian cancer
platinum resistant